Skip to content

Clinical trials

Enrolling by invitation Phase 3 trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Enrolling by invitation Country / region: Czechia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20213
20224
20233
20244
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
UCB Biopharma SRL2
Viatris Innovation GmbH2
ACADIA Pharmaceuticals Inc.1
Alnylam Pharmaceuticals1
AstraZeneca1
Astria Therapeutics, Inc.1
BioCryst Pharmaceuticals1
Biogen1
Celldex Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases3
Lupus Erythematosus, Systemic3
Amyloidosis2
Angioedemas, Hereditary2
Immune System Diseases2
Angioedema1
Asthma1
Autoimmune Diseases1
Cardiomyopathies1
Cardiovascular Diseases1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.